<\/p>\n
Busiron (Buspirone 5 \/ 10 mg) is a 5-HT1A partial agonist for generalised anxiety disorder. Non-sedating, non-addictive, no abuse potential \u2014 but slow onset (3\u20136 weeks). Useful when benzodiazepines are inappropriate.<\/p>\n<\/div>\n
\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n Busiron at MedsBase is supplied directly from a WHO-GMP certified manufacturer in plain, discreet packaging. Every order is covered by our Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a> \u2014 20pracovn\u00edchdenn\u00ed lh\u016fta pro doru\u010den\u00ed, nebo v\u00e1m z\u00e1silku zdarma p\u0159epo\u0161leme \u2014 a oprav\u0148uje v\u00e1s k \u00fa\u010dasti v na\u0161em v\u011brnostn\u00edm programu<\/a>. Dod\u00e1v\u00e1me do v\u011bt\u0161iny zem\u00ed po cel\u00e9m sv\u011bt\u011b.<\/p>\n Busiron is a 5 \/ 10 mg buspirone tablet supplied by Intas. Buspirone is a partial agonist at 5-HT1A serotonin receptors and a weak D2 antagonist. The 5-HT1A action reduces anxiety over weeks of dosing; the absence of GABA-A interaction explains why buspirone produces neither sedation, nor amnesia, nor dependence \u2014 distinguishing it sharply from benzodiazepines.<\/p>\n Buspirone takes 3\u20136 weeks to reach full anxiolytic effect. It does not work as a PRN agent and does not produce immediate calming. Patients who expect benzodiazepine-like relief in the first week will conclude buspirone “doesn’t work” and stop. Set the expectation up front.<\/p>\n<\/div>\nPro\u010d objedn\u00e1vat z MedsBase<\/h3>\n
What Busiron is and how it works<\/h2>\n
Indikace a d\u00e1vkov\u00e1n\u00ed<\/h2>\n